SCHEMBL1995232

SCHEMBL1995232

O=S(=O)(c1ccc(-c2cc(F)ccc2O)cc1F)c1ccccc1Cl

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGDR2 Q9Y5Y4 1/20 0.39
ALOX5AP P20292 4/20 0.39
FEN1 P39748 4/20 0.39
PTGS2 P35354 2/20 0.38
PTGS1 P23219 1/20 0.38
PIN1 Q13526 1/20 0.38
ACLY P53396 4/20 0.37
KDM4E B2RXH2 1/20 0.36
MEN1 O00255 1/20 0.36
USP2 O75604 1/20 0.36
ALDH1A1 P00352 1/20 0.36
DHFR P00374 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
LMNA P02545 1/20 0.36
TTR P02766 1/20 0.36
ALB P02768 1/20 0.36
HMGB1 P09429 1/20 0.36
HPGD P15428 1/20 0.36
CXCL12 P48061 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1996020 0.90 HTR2A (0.43) ALOX5APFEN1PIN1ACLYKDM4E
SCHEMBL1989399 0.83 POLB (0.47) PTGDR2ALOX5APFEN1PIN1KDM4E
SCHEMBL1998315 0.82 NR3C1 (0.49) PTGS2PTGS1PIN1ACLYPTGES2
SCHEMBL1992954 0.81 POLB (0.44) PTGDR2PTGS2PTGS1PIN1ACLY
SCHEMBL13210566 0.81 PTGDR2 (0.45) PTGDR2LMNAHTR2AHTR2C
SCHEMBL1988525 0.80 GRM5 (0.46) FEN1PIN1KDM4EMEN1USP2
SCHEMBL1991023 0.79 PTGDR2 (0.48) PTGDR2ALOX5APFEN1ACLY
SCHEMBL2347649 0.76 PTGDR2 (0.40) PTGDR2ALOX5APFEN1
SCHEMBL1993521 0.76 POLB (0.46) PTGDR2PTGS2PTGS1MEN1KMT2A
SCHEMBL1990281 0.73 PKM (0.43) PTGDR2PTGS2PTGS1MEN1USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8415394-B2 Biphenyloxyacetic acid derivatives for the treatment of respiratory disease ASTRAZENECA AB (GB) 2013-04-09 US disclosed
US-8349897-B2 Biphenyloxyacetic acid derivatives for the treatment of respiratory disease ASTRAZENECA AB (SE) 2013-01-08 US disclosed
US-20120178814-A1 Biphenyloxyacetic Acid Derivatives for the Treatment of Respiratory Disease LUKER TIMOTHY JON (GB) 2012-07-12 US disclosed
US-8008350-B2 Biphenyloxyacetic acid derivatives for the treatment of respiratory disease ASTRAZENECA AB (SE) 2011-08-30 US disclosed
US-20110152374-A1 Biphenyloxyacetic Acid Derivatives for the Treatment of Respiratory Disease ASTRAZENECA AB (SE) 2011-06-23 US disclosed
EP-1937633-B1 BIPHENYLOXYACETIC ACID DERIVATIVES FOR THE TREATMENT OF RESPIRATORY DISEASE ASTRAZENECA AB (SE) 2010-08-04 EP disclosed
US-20090036535-A1 Biphenyloxyacetic Acid Derivatives for the Treatment of Respiratory Disease ASTRAZENECA AB (SE) 2009-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120178814-A1 Biphenyloxyacetic Acid Derivatives for the Treatment of Respiratory Disease BPGM, PPARA, HPD PTGDR2 568/4885ALOX5AP 701/4885FEN1 4495/4885
US-20110152374-A1 Biphenyloxyacetic Acid Derivatives for the Treatment of Respiratory Disease BPGM, PPARA, HPD PTGDR2 568/4885ALOX5AP 701/4885FEN1 4495/4885
US-20090036535-A1 Biphenyloxyacetic Acid Derivatives for the Treatment of Respiratory Disease BPGM, PPARA, HPD PTGDR2 568/4885ALOX5AP 701/4885FEN1 4495/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.